Investor Relations

Investor Relations

Corporate Profile

Itamar Medical is a medical technology company focused on the development and commercialization of non-invasive medical devices to aid in the diagnosis of respiratory sleep disorders. We commercialize a digital healthcare platform to facilitate the continuum of care for effective sleep apnea management with a focus on the core sleep, cardiology and direct to consumer markets.

Our prescription WatchPAT family of products, which utilizes the PAT signal, is designed to enable patients suspected to have sleep related breathing disorders to easily conduct sleep apnea tests in the comfort of their homes in accordance with a physician’s instructions, as authorized by qualified medical personnel while delivering the treating physicians with comprehensive, accurate and reliable results to aid in the diagnosis of sleep apnea.

 
Stock Information
Press Releases
Apr
2020
Itamar™ Medical and BetterNight to Join Forces Offering Referred Patients Home Based Virtual-Care Sleep Solution for the Diagnosis and Treatment of Sleep Apnea
Mar
2020
Itamar™ Medical Implements Broad Range of Actions in Response to COVID-19 Pandemic
Mar
2020
Itamar™ Medical Reports Record Fourth Quarter and Full Year 2019 Revenues
Mar
2020
Itamar™ Medical and Clalit Research Institute Establish Research Collaboration to Explore WatchPAT Signals’ Ability to Predict Health Outcomes Using Existing Big Data and Artificial Intelligence
Feb
2020
ItamarTM Medical to Report Fourth Quarter and Full Year 2019 Financial Results and Host Conference Call on Tuesday, March 3, 2020
Feb
2020
Itamar™ Medical Announces Publication of COMPASS Study Validating First Scoring Guidelines for WatchPAT™ Device in Diagnosing Sleep Apnea
Investor Events
Mar
2020
Fourth Quarter 2019 Financial Results
Dec
2019
Piper Jaffray Healthcare Conference
Nov
2019
Third Quarter 2019 Financial Results
Oct
2019
Ladenburg Thalmann 2019 Healthcare Conference
Investor Presentations
Management